Financhill
Back

Amarin Corp PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
31

AMRN
Amarin Corp PLC

Last Price:
0.60
Seasonality Move:
2.5%
Sell
15

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.95
Seasonality Move:
-15.94%
Sell
31
Amarin Corp PLC (AMRN) is a Sell

Is Amarin Corp PLC a Buy, Sell or Hold?

  • The current Amarin Corp PLC [AMRN] share price is $0.61. The Score for AMRN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • AMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.95. The Score for ADAP is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AMRN Stock Price Chart

What is Amarin Corp PLC's stock price today?

  • The Amarin Corp PLC share price today is $0.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

AMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 49.5 Sell
Chaikin Money Flow: 391355 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.62) Buy
Bollinger Bands (100): (0.6 - 0.8) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 43.09 Sell
Chaikin Money Flow: 478500 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.93 - 1.13) Sell
Bollinger Bands (100): (0.96 - 1.22) Sell

AMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.6 Buy
20-day SMA: 0.59 Buy
50-day SMA: 0.63 Sell
200-day SMA: 0.86 Sell
8-day EMA: 0.6 Buy
20-day EMA: 0.6 Buy
50-day EMA: 0.63 Sell
200-day EMA: 0.81 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.93 Buy
20-day SMA: 1 Sell
50-day SMA: 1.1 Sell
200-day SMA: 1.12 Sell
8-day EMA: 0.94 Buy
20-day EMA: 0.99 Sell
50-day EMA: 1.06 Sell
200-day EMA: 1.09 Sell

Amarin Corp PLC Earnings Growth & AMRN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.06 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.

Amarin Corp PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):